1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Insight Pharma Reports Announces High-Content Analysis:Technologies, Applications, & Market Dynamics

This Insight Pharma Report focuses on the applications, technology and market aspects of high-content analysis.

FOR IMMEDIATE RELEASE

 
 
InsightPharmaReports com
InsightPharmaReports com
PRLog (Press Release) - Jan. 9, 2012 - NEEDHAM, MASS. – Cambridge Healthtech Institute’s Insight Pharma Reports announces the High-Content Analysis: Technologies, Applications, and Market Dynamics report, authored by, Ken Rubenstein, PhD.

This Insight Pharma Report focuses on the applications, technology and market aspects of high-content analysis (HCA)—a field that originated when automated microscopic imaging technology joined with the high-throughput screening paradigm that signified the birth of “industrialized drug discovery.”  This report discusses:  
       
•   Development of the HCA field from the commercial, scientific, and technological perspectives
•   Technologies that underlie HCA and the full range of systems that are available today
•   Applications of HCA in areas including cell signaling, cell and organism physiology, toxicology, target validation, and drug discovery
•   Market dynamics, including a competitive analysis and an examination of recent HCA deals
•   Results from an Insight Pharma Reports online survey of people who are active in the HCA field
•   Interviews with individuals who are highly knowledgeable in the HCA field, which were conducted exclusively for this report  

High-throughput screening (HTS), used for the en masse discovery of compounds that  interact with molecular drug targets, provides many more hits than viable drug candidates. In the last decade, HCS (high-content screening), based largely on automated imaging technology, has come to provide a form      of secondary screening in which hits can be tested efficiently for their effects on cells. Applications of HCS have diversified into what is now called HCA (high-content analysis), a more generalized term that covers areas such as target identification, pathway analysis, mechanism of action verification, and cell biology research in general.

High-Content Analysis: Technologies, Applications, and Market Dynamics begins by examining the evolution and nature of HCA. The several variant definitions of HCA/HCS that have been offered are addressed, before turning to an examination of the technological aspects of HCA. In addition to automated microscopic imaging systems, also covered are flow cytometry from the HCA perspective, live cell and kinetic HCA, the role of primary cells and stem cells, and the nature of informatics systems supporting HCA investigations.

This report next addresses HCA applications in areas that include cell signaling, cell and organism physiology, toxicology, and target identification and validation before turning specifically to applications in drug discovery, including primary and secondary screening. Other topics covered are the role of service organizations, the nature and sources of cells and other sample types, and applications in cell biology research.

High-Content Analysis: Technologies, Applications, and Market Dynamics then turns to an analysis of market dynamics in terms of the competitive landscape among vendors, deals and deal patterns, and results from a survey of individuals who use HCA. We conclude by summarizing our findings, discussing possible future directions in the HCA field, and addressing the key questions:

•   Why are so many large companies interested in HCA?
•   What do HCA systems manufacturers need to do to keep the market growing at a healthy clip?
•   Is HCA making a significant impact on drug discovery?        

For more information and to purchase this Insight Pharma Report, visit: http://www.InsightPharmaReports.com

About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute.  http://www.InsightPharmaReports.com

# # #

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets.

Photo:
http://www.prlog.org/11767166/1

--- End ---

Click to Share

Contact Email:
***@healthtech.com Email Verified
Source:Insight Pharma Reports
Phone:781-972-5444
Zip:02494
City/Town:Needham - Massachusetts - United States
Industry:Biotech, Science, Technology
Tags:high content analysis, hca, market research, pharma, biotech, market report, drug discovery, life sciences, Technology
Shortcut:prlog.org/11767166
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share